2024 KSoLA Update on New Lipid-Lowering Agents: Inclisiran and Bempedoic Acid

Inclisiran and bempedoic acid (BA) are non-statin lipid-lowering agents that have been approved for use in the US and Europe. Inclisiran, a subcutaneously administered small interfering RNA targeting proprotein convertase subtilisin/kexin type 9 messenger RNA, is effectively delivered to the liver v...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hack-Lyoung Kim, Jung-Joon Cha, Sang-Hak Lee, on behalf of the Clinical Practice Guidelines Committee, Korean Society of Lipid and Atherosclerosis (KSoLA)
Format:	Artigo
Jezik:	Inglês
Izdano:	The Korean Society of Lipid and Atherosclerosis 2025-05-01
Serija:	Journal of Lipid and Atherosclerosis
Teme:	coronary artery disease pharmacology lipoproteins safety
Online dostop:	https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2025.14.2.135&code=9992JLA&vmode=FULL
Oznake:	Označite Brez oznak, prvi označite!